153 results
8-K
EX-10.1
INM
InMed Pharmaceuticals Inc
9 Feb 24
InMed Pharmaceuticals Strengthens Executive Leadership Team with Appointment of Ms. Netta Jagpal as Chief Financial Officer
12:34pm
aforesaid is accepted voluntarily for the purpose of employment with the Company under the terms and conditions described herein.
Use of Discretion … or recollections thereof for any purpose other than the performance of the Services for the benefit of the Company and its Affiliates;
(ii)
publish
424B3
INM
InMed Pharmaceuticals Inc
13 Nov 23
Prospectus supplement
5:05pm
for that purpose is required, other than in the United States. Persons who come into possession of this prospectus in a jurisdiction outside the United … for the purpose of computing the percentage of Common Shares owned by such person or group. However, such unissued Common Shares described above
8-K
EX-10.2
aw1hy4 y7bhx
27 Oct 23
Entry into a Material Definitive Agreement
7:16pm
8-K
EX-10.1
4v4bgd 9cyzxtdrhxi
27 Oct 23
Entry into a Material Definitive Agreement
7:16pm
8-K
EX-4.2
aw9r5
27 Oct 23
Entry into a Material Definitive Agreement
7:16pm
8-K
EX-10.3
5kb8d3r gpl0ic3
27 Oct 23
Entry into a Material Definitive Agreement
7:16pm
8-K
EX-4.1
6u8ohh
27 Oct 23
Entry into a Material Definitive Agreement
7:16pm
8-K
EX-4.3
6tf3ojwlsww6wr5 v2k
27 Oct 23
Entry into a Material Definitive Agreement
7:16pm
8-K
EX-99.1
2dj7r8lx
22 Jun 23
InMed Pharmaceuticals Inc. Announces Results from a Phase 2 Clinical Trial in Epidermolysis Bullosa
4:28pm
424B3
inv6 535gxb
15 Dec 22
Prospectus supplement
11:42am
8-K
EX-10.2
tubprfln9o3
13 Dec 22
InMed Announces Appointment of Interim Chief Financial Officer and Change of Auditor
3:47pm